GenZum Life Sciences

Recent Finacing

Equity

Recent Raise

$20M

Genzum develops, commercializes and out-licenses niche ANDA generic pharmaceuticals, operating facilities and end-to-end capabilities for product selection, formulation, clinical trials and FDA regulatory approval.